Sanofi Consumer Healthcare India Ltd vs Vineet Laboratories Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 09, 2026

Key Highlights

The Latest Trading Price of Sanofi Consumer Healthcare India Ltd is ₹ 4773 as of 08 May 15:30 . The P/E Ratio of Sanofi Consumer Healthcare India Ltd changed from 62.6 on December 2024 to 62.6 on December 2024 . This represents a CAGR of 0.00% over 1 yearsThe P/E Ratio of Vineet Laboratories Ltd changed from 6.6 on March 2022 to 0 on December 2024 . This represents a CAGR of -100.00% over 6 years The Market Cap of Sanofi Consumer Healthcare India Ltd changed from ₹ 11347 crore on December 2024 to ₹ 11347 crore on December 2024 . This represents a CAGR of 0.00% over 1 yearsThe Market Cap of Vineet Laboratories Ltd changed from ₹ 43.7 crore on March 2022 to ₹ 0 crore on December 2024 . This represents a CAGR of -100.00% over 6 years The revenue of Sanofi Consumer Healthcare India Ltd for the Jun '26 is ₹ 234.8 crore as compare to the Mar '25 revenue of ₹ 0 crore. This represent the growth of 9.2233718E16% The revenue of Vineet Laboratories Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '25 revenue of ₹ 15.46 crore. This represent the decline of -100% The ebitda of Sanofi Consumer Healthcare India Ltd for the Jun '26 is ₹ 94.4 crore as compare to the Mar '25 ebitda of ₹ 0 crore. This represent the growth of 9.2233718E16% The ebitda of Vineet Laboratories Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '25 ebitda of ₹ -9.66 crore. This represent the decline of -100% The net profit of Sanofi Consumer Healthcare India Ltd changed from ₹ 62.7 crore to ₹ 67.8 crore over 8 quarters. This represents a CAGR of 3.99% The net profit of Vineet Laboratories Ltd changed from ₹ -2.13 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of -100.00% The Dividend Payout of Sanofi Consumer Healthcare India Ltd changed from 6.06 % on December 2023 to 69.89 % on December 2024 . This represents a CAGR of 239.60% over 2 yearsThe Dividend Payout of Vineet Laboratories Ltd changed from 13.89 % on March 2022 to 0 % on December 2024 . This represents a CAGR of -100.00% over 6 years .

About Sanofi Consumer Healthcare India Ltd

Sanofi Consumer Healthcare India Limited was incorporated on May 10, 2023, as part of Sanofi's global strategy to establish a standalone Consumer Healthcare business.
This strategic move resulted in the demerger of the Consumer Healthcare business from Sanofi India Limited (SIL) into the Company through a Scheme of Arrangement, thereby creating a distinct legal entity.
The Scheme of Arrangement, which was sanctioned by the National Company Law Tribunal, Mumbai (NCLT) enabled the seamless transfer and vesting of all assets, liabilities, and operations of SIL to the Company. Pursuant to the Scheme becoming effective, the Consumer Healthcare Division (CHC) business of Sanofi India Limited (SIL) got demerged into the Company as a going concern through the Scheme of Arrangement and became effective from June 1, 2024.

About Vineet Laboratories Ltd

Vineet Laboratories Limited, formerly known as Ortin Laboratories Limited is a manufacturing company of intermediates useful for the manufacture of active pharmaceutical ingredients.
The Company was incorporated on 10 November 2016 and operates in the business of in the manufacture of Drug Intermediates & Bulk Dugs.
The name of the Company changed to Vineet Laboratories Limited, on account of demerger in December, 2020. The production unit located at Malkapur Village, Yadadri- Bhuvanagiri District in Telangana State, India, is a multipurpose facility well equipped with stainless steel and glass-lined reactors with total volume of 230KL, of different volumes to suit any batch size.
Special provisions are made to carry out reactions at very low temperature (up to -100°C).
The Company is also specialized in manufacturing and handling pyrophoric chemicals like n-Butyl Lithium.

FAQs for the comparison of Sanofi Consumer Healthcare India Ltd and Vineet Laboratories Ltd

Which company has a larger market capitalization, Sanofi Consumer Healthcare India Ltd or Vineet Laboratories Ltd?

Market cap of Sanofi Consumer Healthcare India Ltd is 10,992 Cr while Market cap of Vineet Laboratories Ltd is 75 Cr

What are the key factors driving the stock performance of Sanofi Consumer Healthcare India Ltd and Vineet Laboratories Ltd?

The stock performance of Sanofi Consumer Healthcare India Ltd and Vineet Laboratories Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Sanofi Consumer Healthcare India Ltd and Vineet Laboratories Ltd?

As of May 9, 2026, the Sanofi Consumer Healthcare India Ltd stock price is INR ₹4773.0. On the other hand, Vineet Laboratories Ltd stock price is INR ₹39.5.

How do dividend payouts of Sanofi Consumer Healthcare India Ltd and Vineet Laboratories Ltd compare?

To compare the dividend payouts of Sanofi Consumer Healthcare India Ltd and Vineet Laboratories Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.